In summary, our results demonstrate for the first time that ASIV could prevent Iso-induced hypertrophy and alleviate energy metabolism disorder, partly through NF-κB/PGC-1α pathway. The gene discussed is PPARGC1A; the disease is Disorder of energy metabolism.